Related Experiment Videos
Hyperlipidemia in children
1Department of Pediatrics, University of Oklahoma Health Sciences Center, Children's Hospital of Oklahoma, Oklahoma City 73104-5066.
Insights
Early atherosclerosis risk in children involves genetic and environmental factors influencing lipid transport. Identifying these risks aids in developing comprehensive cardiovascular health strategies for adults.
Area of Science:
- Cardiovascular science
- Lipid metabolism
- Atherosclerosis research
Background:
- Atherosclerosis pathogenesis begins in childhood, influenced by genetic and environmental factors.
- Lipoprotein transport disorders contribute to cardiovascular disease risk.
- Understanding these factors is crucial for early intervention.
Purpose of the Study:
- To classify genetic lipoprotein disorders based on atherogenicity.
- To explore methods for assessing multifactorial lipid transport influences.
- To inform comprehensive cardiovascular health intervention strategies.
Main Methods:
- Classification of genetic disorders by lipoprotein density class and lipid profiles.
- Assaying apolipoproteins, receptors, enzymes, and variant genes.
- Assessing apolipoprotein particle composition using immunologic precipitation.
Main Results:
- Genetic disorders can be categorized by their impact on lipid profiles and atherogenicity.
- Serial immunologic precipitation offers a cost-effective assessment of multifactorial lipid transport influences.
- Identification of inherited risk and non-genetic factors is feasible.
Conclusions:
- Early identification of inherited and environmental risk factors is key to improving adult cardiovascular health.
- Comprehensive strategies should address genetic predispositions and lifestyle influences.
- Targeted interventions can mitigate atherosclerosis development from childhood.
Abstract:
Advances toward improving cardiovascular health of tomorrow's adults lie both in acknowledging that the pathogenesis of atherosclerosis begins in childhood and in considering the influence of environmental factors on genetic endowment of risk. Based on current understanding of lipoprotein transport processes, an array of genetic disorders with various degrees of atherogenicity can be classified according to the predominant lipoprotein density class, as represented by a standard lipid profile, and then further defined by assaying apolipoproteins and their receptors, lipoprotein transport enzymes, or the respective variant genes. Alternatively, a simple and potentially cost-effective representation of multifactorial influences on lipid transport is provided by an assessment of apolipoprotein particle composition using serial immunologic precipitation of apolipoproteins while on their intact plasma lipoproteins. A comprehensive intervention strategy can be based on identification of inherited risk and the effects of nongenetic factors, which include dietary excess, inactivity, disease states, and medications.